Clinical Trials Directory

Trials / Completed

CompletedNCT05120713

Noradrenergic Activity and Attention

The Influence of Noradrenergic Activity on Attentional Control in Younger and Older Adults

Status
Completed
Phase
Study type
Observational
Enrollment
140 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Older adults demonstrate increased distractibility by task-irrelevant information which contributes to general cognitive impairment. However, it is yet unclear how changes in noradrenergic activity during aging influences attentional control. In the current study, tonic noradrenergic activity will be increased or decreased to investigate its behavioral and neural effects on attentional control.

Conditions

Timeline

Start date
2021-11-01
Primary completion
2023-11-20
Completion
2023-11-20
First posted
2021-11-15
Last updated
2024-09-19
Results posted
2024-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05120713. Inclusion in this directory is not an endorsement.

Noradrenergic Activity and Attention (NCT05120713) · Clinical Trials Directory